Based on this, we hypothesized that inhibiting FAK by ceritinib will improve PTX-induced apoptosis in AR− or ARlow TNBCs, and the combination of ceritinib and PTX will have an enhanced inhibitory effect on tumor cell growth. Here, PTK2 is linked to neoplasm.